☰

Anne Schmechtig, PhD - Publications

Affiliations: 
Neuroimaging Institute of Psychiatry, Charleston, SC, United States 
Tree Info Grants Similar researchers PubMed Report error

23/25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Kumari V, Antonova E, Wright B, Hamid A, Hernandez EM, Schmechtig A, Ettinger U. The mindful eye: Smooth pursuit and saccadic eye movements in meditators and non-meditators. Consciousness and Cognition. 48: 66-75. PMID 27842243 DOI: 10.1016/J.Concog.2016.10.008  0.445
2016 Koychev I, Joyce D, Barkus E, Ettinger U, Schmechtig A, Dourish CT, Dawson GR, Craig KJ, Deakin JF. Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies. Translational Psychiatry. 6: e811. PMID 27187233 DOI: 10.1038/Tp.2016.64  0.538
2015 Kumari V, Ettinger U, Lee SE, Deuschl C, Anilkumar AP, Schmechtig A, Corr PJ, Ffytche DH, Williams SC. Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology. PMID 25980483 DOI: 10.1007/S00213-015-3959-1  0.606
2013 Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, et al. The effects of ketamine and risperidone on eye movement control in healthy volunteers. Translational Psychiatry. 3: e334. PMID 24326395 DOI: 10.1038/Tp.2013.109  0.588
2013 Perkins AM, Ettinger U, Weaver K, Schmechtig A, Schrantee A, Morrison PD, Sapara A, Kumari V, Williams SC, Corr PJ. Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Translational Psychiatry. 3: e246. PMID 23591970 DOI: 10.1038/Tp.2013.20  0.477
2013 Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, Deakin JF, Dourish CT, Koychev I, McMullen K, Migo EM, Perry C, Wilkinson L, Morris R, Williams SC, et al. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology. 227: 331-45. PMID 23430159 DOI: 10.1055/S-0031-1292540  0.548
2013 Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JFW, et al. Differential effect of amisulpride on cognition in schizotypy: validation of models for the early identification of cognitive enhancing agents The Lancet. 381: 59-59. DOI: 10.1016/S0140-6736(13)60499-7  0.544
2012 Owens SF, Picchioni MM, Ettinger U, McDonald C, Walshe M, Schmechtig A, Murray RM, Rijsdijk F, Toulopoulou T. Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain : a Journal of Neurology. 135: 2231-44. PMID 22693145 DOI: 10.1093/Brain/Aws138  0.576
2012 Völter C, Riedel M, Wöstmann N, Aichert DS, Lobo S, Costa A, Schmechtig A, Collier DA, Hartmann AM, Giegling I, Möller HJ, Quednow BB, Rujescu D, Kumari V, Ettinger U. Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1427-40. PMID 22244514 DOI: 10.1017/S1461145711001787  0.517
2012 Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, Schmechtig A, Walters J, Craig KJ, Dawson GR, Dourish CT, Ettinger U, Wilkinson L, Williams S, Deakin JF, et al. A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 469-81. PMID 22137565 DOI: 10.1016/J.Euroneuro.2011.10.005  0.547
2012 Ettinger U, Schmechtig A, Toulopoulou T, Borg C, Orrells C, Owens S, Matsumoto K, van Haren NE, Hall MH, Kumari V, McGuire PK, Murray RM, Picchioni M. Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia. Schizophrenia Bulletin. 38: 192-203. PMID 20538831 DOI: 10.1093/Schbul/Sbq060  0.612
2011 Kempton MJ, Underwood TS, Brunton S, Stylios F, Schmechtig A, Ettinger U, Smith MS, Lovestone S, Crum WR, Frangou S, Williams SC, Simmons A. A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method. Neuroimage. 58: 1051-9. PMID 21835253 DOI: 10.1016/J.Neuroimage.2011.06.080  0.42
2011 Quednow BB, Ettinger U, Mössner R, Rujescu D, Giegling I, Collier DA, Schmechtig A, Kühn KU, Möller HJ, Maier W, Wagner M, Kumari V. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6684-91. PMID 21543597 DOI: 10.1523/Jneurosci.0526-11.2011  0.612
2011 Owens S, Ettinger U, Picchioni M, McDonald C, Rijsdijk F, Schmechtig A, Walshe M, Rebollo-Mesa I, van Haren N, Murray R, Toulopoulou T. Prefrontal cortex ROI’s as endophenotypes, testing genetic overlap their with schizophrenia and neurocognitve endopheno-types International Clinical Psychopharmacology. 26: e156-e157. DOI: 10.1097/01.Yic.0000405906.72859.Dd  0.548
2010 Crawford TJ, Hamm JP, Kean M, Schmechtig A, Kumari V, Anilkumar AP, Ettinger U. The perception of real and illusory motion in schizophrenia. Neuropsychologia. 48: 3121-7. PMID 20600182 DOI: 10.1016/J.Neuropsychologia.2010.06.027  0.541
2010 Schmechtig A, Vassos E, Kumari V, Hutton SB, Collier DA, Morris RG, Williams SC, Ettinger U. Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements. Genes, Brain, and Behavior. 9: 621-7. PMID 20497232 DOI: 10.1111/J.1601-183X.2010.00594.X  0.558
2010 Petrovsky N, Quednow BB, Ettinger U, Schmechtig A, Mössner R, Collier DA, Kühn KU, Maier W, Wagner M, Kumari V. Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1429-39. PMID 20393456 DOI: 10.1038/Npp.2010.12  0.599
2009 Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, Collier DA, Vollenweider FX, Wagner M, Kumari V. Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biological Psychiatry. 66: 614-20. PMID 19545856 DOI: 10.1016/J.Biopsych.2009.05.007  0.524
2009 Petrovsky N, Schmechtig A, Flomen RH, Kumari V, Collier D, Makoff A, Wagner M, Ettinger U. CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 267-73. PMID 19149910 DOI: 10.1017/S1461145708009784  0.552
2009 Kempton MJ, Ettinger U, Schmechtig A, Winter EM, Smith L, McMorris T, Wilkinson ID, Williams SC, Smith MS. Effects of acute dehydration on brain morphology in healthy humans. Human Brain Mapping. 30: 291-8. PMID 18064587 DOI: 10.1002/Hbm.20500  0.413
2009 Schmechtig A, Vassos E, Kumari V, Hutton S, Collier D, Morris R, Williams S, Ettinger U. Association of Neuregulin 1 rs3924999 with oculomotor endophenotypes for schizophrenia in healthy volunteers Pharmacopsychiatry. 42. DOI: 10.1055/S-0029-1240217  0.594
2008 Ettinger U, Picchioni M, Schmechtig A, Kumari V, Matsumoto K, Van Haren N, Marshall N, Hall M, Schulze K, Toulopoulou T, Williams S, McGuire P, Murray R. 221 – Magnetic resonance imaging of the frontal lobe in twins with schizophrenia Schizophrenia Research. 98: 124-125. DOI: 10.1016/J.Schres.2007.12.288  0.543
2008 Schmechtig A, Picchioni M, Ettinger U, Kumari V, Matsumoto K, Van Haren N, Marshall N, Hall M, Schulze K, Toulopoulou T, Davies N, Ribchester T, Williams S, McGuire P, Murray R. Magnetic resonance imaging of the frontal lobe in twins with schizophrenia European Psychiatry. 23: S144. DOI: 10.1016/J.Eurpsy.2008.01.883  0.547
Low-probability matches (unlikely to be authored by this person)
2011 Koychev I, McMullen K, Lees J, Grayson L, Schmechtig A, Dourish C, Wilkinson L, Williams S, Deakin JFW, Barkus E. S.07.08 A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy European Neuropsychopharmacology. 21: 469-481. DOI: 10.1016/S0924-977X(11)70099-2  0.281
2018 Mehta MA, Schmechtig A, Kotoula V, McColm J, Jackson K, Brittain C, Tauscher-Wisniewski S, Kinon BJ, Morrison PD, Pollak T, Mant T, Williams SCR, Schwarz AJ. Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology. PMID 29564482 DOI: 10.1007/S00213-018-4877-9  0.279
Hide low-probability matches.